Clinical Trial

Dupixent in Adults With Refractory Post-Burn Pruritus in an Ambulatory Clinic

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2025 (before its estimated January 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this study is to test the efficacy of Dupixent in improving post-burn itching symptoms versus the current standard of care.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-01-18; most recent amendment 2025-09-16.
Status change: Not Yet Recruiting → Recruiting 2024-12-02
Trial Details
NCT Number NCT06226610
Lead Sponsor Akron Children's Hospital
Collaborators: Regeneron Pharmaceuticals, Ohio State University
Conditions Pruritis
Enrollment 46 participants
Start Date 2024-11-21
Primary Completion 2026-01-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-19